Welcome to our dedicated page for Exxonmobil Holdings Corporation SEC filings (Ticker: XOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exxon Mobil Corporation filings document formal disclosures for an integrated energy and petrochemical issuer with common stock and several note securities registered on the New York Stock Exchange. Form 8-K reports furnish operating results, earnings-release exhibits, Regulation FD materials, market and planned-factor earnings considerations, and updates tied to global operating conditions.
The filing record also includes proxy materials covering board elections, governance and shareholder voting, along with material-event reports on executive officer and director changes. Capital-structure disclosures include shelf-registration usage, underwriting agreements, indenture supplements and officer certificates for ExxonMobil debt securities, including floating-rate notes and previously registered notes.
ExxonMobil reported third‑quarter 2025 results. Total revenues and other income were $85.3 billion, with net income of $7.55 billion and EPS of $1.76, compared to $90.0 billion, $8.61 billion, and $1.92 a year earlier. Management cited weaker crude prices, lower chemical margins, and higher growth expenses, partly offset by stronger refining margins, higher Upstream volumes in Guyana and the Permian, and Structural Cost Savings.
For the first nine months of 2025, revenues and other income were $249.9 billion and net income was $22.34 billion (EPS $5.16). Operating cash flow reached $39.29 billion, funding $20.91 billion of capital expenditures, $12.87 billion in dividends, and $14.89 billion of share repurchases. Cash and equivalents were $13.87 billion at period end, and long‑term debt was $32.82 billion. Shares outstanding were 4,217,165,614 as of September 30, 2025.
ExxonMobil completed $2.4 billion of acquisitions in the Permian during the quarter, primarily acreage, recorded to property, plant and equipment with no goodwill recognized.
Exxon Mobil Corporation (XOM) furnished materials announcing third quarter 2025 results via an 8-K. The company provided a News Release dated October 31, 2025 and a 3Q25 Investor Relations Data Summary as Exhibits 99.1 and 99.2.
The disclosure was made pursuant to Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD). Common stock and select notes (0.524% due 2028, 0.835% due 2032, 1.408% due 2039) are listed on the NYSE.
Exxon Mobil Corporation furnished an update related to its upcoming third-quarter 2025 results. Through this Form 8-K, the company provided an exhibit titled “Exxon Mobil Corporation 3Q25 Earnings Considerations” under a Regulation FD disclosure item. This type of filing is used to share information with all investors at the same time, often ahead of or alongside earnings announcements. The document itself does not include financial results but points investors to the separate earnings considerations materials in Exhibit 99.1.
Insider sale reported: The Form 4 shows that Darrin L. Talley, a vice president in corporate strategic planning at Exxon Mobil Corporation (XOM), sold 2,158 shares of Common Stock on 08/22/2025 at a price of $110.4501 per share. The filing lists several categories of beneficial ownership following the reported transaction, including 13,829 shares held indirectly by a revocable trust, 3,295 in a brokerage account, 8,239 by a family trust, 6,511.1801 in a savings plan, and 100 shares held by a dependent child.
Form details and signature: The Form 4 was signed by Marsha E. Stewart Schreiner by power of attorney on 08/25/2025. The filing does not include commentary on the reason for the sale or any 10b5-1 plan indication on the presented pages.
Exxon Mobil’s Q2 2025 10-Q shows weaker top-line and bottom-line results but continued strong cash generation and balance-sheet discipline. Sales & other operating revenue fell 11.7% YoY to $79.5 bn, driving total revenues to $81.5 bn (-12%). Net income attributable to XOM dropped 23% to $7.1 bn, and diluted EPS slipped to $1.64 from $2.14. For 1H 2025, revenue declined 6.6% to $160.5 bn while net income of $14.8 bn was 15% lower than a year ago.
Operating cash flow remained robust at $24.5 bn (-3%), comfortably covering $12.2 bn of capex and enabling $9.8 bn of share repurchases plus $8.6 bn in dividends (1H dividend per share $1.98). Free cash flow of roughly $12.3 bn and a $3.2 bn reduction in long-term debt cut gross debt to $33.6 bn; net cash fell to $14.4 bn from $23.0 bn as buybacks and capex outpaced inflows. Share count stood at 4.263 bn outstanding.
Upstream remained the earnings engine (Q2 $5.4 bn segment profit) but Energy Products margins compressed sharply, and Chemical Products stayed near cycle lows. Foreign-exchange translation gains added $2.2 bn to OCI, lifting total equity to $270 bn. Management reports cumulative structural cost savings of $13.5 bn versus 2019. Integration of the $63 bn Pioneer acquisition (545 m shares issued, $5 bn debt assumed) progressed with no new identified items. No material litigation or contingent liabilities were recorded.